Replies to post #340311 on Innovation Pharmaceuticals Inc (IPIX)

[steelyeye]

Yes, I agree... this should get re-priced a lot higher as the dominoes start to fall:

--trial commencement

--more and wider press coverage

--need for therapeutics

--government looking to fund therapeutics

--short phase 2 clinical trial

--a low bar from the competition


and just look at the market caps of other OTC darlings!

A sharp upward revision in sp is looking good with trials to start anytime now and a government looking to fund therapeutics. Sector sentiment is about to change for the better and why shouldn’t Ipix become the next COVID-19 darling of the market. Could they fly? I believe they could.